Yes STI is a specy stock - but potential for some huge advances in the next 6-12months. I saw the latest announcement as positive - as a business you always have to be on the look out for ways to vertically integrate your business and this one can potentially be a deal breaker.
I do agree that the penthouse could have waited...
Still will be interesting to see what is happening with the trials on TB/HIV in Africa.
Immunoxel also has the potentials for superior normalizing and restorative action on the immune system that can be used as a safe and effective means for prevention or treatment of multiple conditions including: influenza, acute respiratory diseases, hepatitis, tuberculosis, herpes, Candida, Chlamydia and other infectious and viral diseases.
Give it time - I picked up some more this morning on the dumps and am extremely happy.
Good luck to holders - and those who do not hold and are negative on the stock - everyone has their views - but not all can agree. The ASX will determine price - my opinion is that SP should be a lot higher - but I am confident that it will get there.
Add to My Watchlist
What is My Watchlist?